Date lodged: 17 March 2017
To ask the Scottish Government what its position is on introducing longer-term funding models for NHS boards to provide more certainty for longer-term plans to identify, diagnose and treat hepatitis C in order to meet its commitment to eliminate the infection as a public health concern by 2030.
Answered by: Aileen Campbell 29 March 2017
NHS Boards fund the treatment of hepatitis C from their overall baseline funding as provided by the Scottish Government. This funding is confirmed following the approval of the Scottish Government’s annual Budget Bill with spending plans outlined each year in the Draft Budget or Scottish Spending Review.
The latest Spending Review covered financial year 2017-18. NHS Boards are currently in the process of preparing 3-year financial plans as part of the annual Local Delivery Plan process. It is a matter for NHS Boards to plan for the provision of Hepatitis C treatments in line with their financial plans.
The current funding and procurement model has allowed significant progress in regards to the treatment of hepatitis C in Scotland, demonstrated by an ambitious target of 1800 initiated treatments in 2017-18 and a 22% reduction in hepatitis
C-related liver failure in 2015.